NORTHCOTT DEVON MEDICAL FOUNDATION — grant history
Latest income
£147k
Grants listed (FY2025)
3
Listed grants total
£21k
Accounts grants total
£21k
listed grants reconcile with the accounts totalextracted from its FY2025 accounts
Grants made, per its accounts filings
| Recipient | Year | Amount | Purpose |
|---|---|---|---|
| Dr A Uren (University of Plymouth) | FY2025 | £8k | Repurposing drugs for the treatment of non-Hodgkin lymphoma. |
| Ms E Walker (University of Plymouth) | FY2025 | £7k | An Ex-Vivo Model to Study the Cellular Uptake and Retention of Indocyanine Green Dye in Liver Tumours |
| Dr L Ries (University of Plymouth) | FY2025 | £6k | The impact of bacterial intra-species variability on Candida albicansStaphylococcus aureus biofilm-associated virulence |
| Dr S Gould | FY2024 | £20k | Characterising subpopulations of senescent cells to safely target treatments for age-mediated disease |
| Dr T Joshi | FY2024 | £10k | Experimental evolutionary analysis of fidaxomicin resistance in the anaerobic pathogen Clostridioides dificile |
| Ms R Moosavi | FY2024 | £4k | An investigation into the effects of factors secreted from metastatic breast cancer cells on the cerebral endothelial surface layer |
| Prof M Upton | FY2024 | £4k | Developing new therapeutic approaches for emerging bacterial pathogens of the human respiratory tract |
| Dr MC Jones | FY2022 | £10k | Defining changes in prostate stromal extracellular matrix during cancer progression and in response to androgen-deprivation therapy |
| Dr N Hill | FY2022 | £10k | Targeting matrix interactions to treat pancreatic cancer |
| Dr A Oguro-Ando | FY2022 | £8k | Investigating the Molecular function of Contactins, a family of APP-interacting proteins, in Alzheimer’s Disease |
| Dr C Clark | FY2022 | £7k | Thresholds used to detect postural hypotension (THUD) - pilot |
| Dr J Carre | FY2022 | £6k | Assessing interactions between energy metabolism, protein balance and insulin in muscle weakness and wasting |
| Dr J Williams | FY2022 | £5k | Accuracy of continuous glucose monitoring in patients on peritoneal dialysis |